FDA Approves GE Healthcare's Software For General Anesthesia Delivery

GE Healthcare, a healthcare arm of General Electric (GE), said on Monday that it has received pre-market approval from the FDA for its End-tidal Control software to assist in the automated delivery of anesthesia and the reduction of greenhouse gas emissions during surgery.

The End-tidal (Et) Control software will be used in the company's Aisys CS2Anesthesia Delivery System.

GE Healthcare will launch the Aisys CS2 Anesthesia Delivery System with the Et Control software in the U.S. in the upcoming months.

The approval was based on the results from the U.S.-based, multi-center, multi-year MASTER-Anesthesia Trial, in which the safety and effectiveness of the Et Control software were evaluated against conventional anesthetic gas delivery methods during general anesthesia in over 200 patients.

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
Home improvement retailer Lowe's Cos., Inc. reported Wednesday an increase in earnings per share for the second quarter that also topped analysts' estimates. However, quarterly sales edged down and missed expectations. The company also reaffirmed its guidance range for the full-year 2022. While reporting financial results for the second quarter on Wednesday, off-price retailer TJX Companies, Inc. (TJX) provided financial outlook for the third and the fourth quarters as well as slashed its guidance for the full-year 2023. For the third quarter, the company projects earnings in a range... American Airlines announced an agreement to purchase up to 20 Overture supersonic jets, the world's fastest airliner, from transportation start-up Boom Supersonic, with an option for an additional 40. Overture, which is expected to carry passengers at twice the speed of the fastest commercial aircraft available at present, would provide an important new speed advantage to American's fleet.
Follow RTT